Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

Combinations of dacarbazine (DTIC) and other cytotoxic agents or alpha-interferon were given to 136 patients in five different regimens. The total response rate was 32% (95% confidence interval 24-40%); 13% had a complete remission. Female patients had a significantly higher chance of response than...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mulder, N. H., van der Graaf, W. T., Willemse, P. H., Koops, H. S., de Vries, E. G., Sleijfer, D. T.
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1994
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033382/
https://ncbi.nlm.nih.gov/pubmed/7522510
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires